Cargando…
In silico inhibition of GABARAP activity using antiepileptic medicinal derived compounds
Epilepsy is a neurological disorder affecting more than 50 million people worldwide. It can be controlled by antiepileptic drugs (AEDs) but more than 30% patients are still resistant to AEDs. To overcome this problem, researchers are trying to develop novel approaches to treat epilepsy including the...
Autores principales: | Mathew, Shilu, Faheem, Muhammad, Al-Malki, Abdulrahman L, Kumosani, Taha A, Qadri, Ishtiaq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479051/ https://www.ncbi.nlm.nih.gov/pubmed/26124559 http://dx.doi.org/10.6026/97320630011189 |
Ejemplares similares
-
In Silico Studies of Medicinal Compounds Against Hepatitis C Capsid Protein from North India
por: Mathew, Shilu, et al.
Publicado: (2014) -
Molecular designing and in silico evaluation of darunavir derivatives as anticancer agents
por: Mahto, Manoj kumar, et al.
Publicado: (2014) -
in Silico investigation of the structural requirements for the AMPA receptor antagonism by quinoxaline derivatives
por: Azam, Faizul, et al.
Publicado: (2013) -
Virtual screening of plant derived compounds for aldose reductase inhibition using molecular docking
por: Muppalaneni, Naresh Babu, et al.
Publicado: (2012) -
Molecular modeling of Ruellia tuberosa L compounds as a-amylase inhibitor: an in silico comparation between human and rat enzyme model
por: Wulan, Dyah Ratna, et al.
Publicado: (2014)